Aztech Global’s Malaysia Facility Obtains FDA Registration for U.S. Medical Device Production

SGX Filings
01/22

Aztech Global Ltd. (8AZ) said on Jan, 22 2026 that its wholly owned manufacturing plant in Pasir Gudang, Johor, IOT Manufacturing Sdn. Bhd., has been registered with the U.S. Food and Drug Administration under 21 CFR Part 807.

The 300,000-square-foot facility, which sits on about 9.11 acres of land, is also ISO 13485 certified, enabling it to produce medical devices under an FDA-aligned quality management system.

With the registration in place, Aztech Global can manufacture, import and market medical devices for customers seeking faster access to the United States, the world’s largest medical device market, valued at roughly 242.3 billion Singapore dollars in 2024.

Malaysia remains a key supply base for the sector, with nearly 37% of its 2024 medical device exports destined for the United States, according to publicly available trade data.

Aztech Global said the new certification complements its existing IoT manufacturing capabilities and supports its strategy to grow as a compliant, scalable partner for medical device owners targeting the U.S. market.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10